|
| 37823694 | Exploring the mechanism of 18F-fluorodopa uptake in recurrent high-grade gliomas: A comprehensive histomolecular-positron emission tomography analysis. | | 2024 |
| 37503540 | A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant. | | 2023 |
| 36180241 | In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of <i>IDH</i>-Mutant Diffuse Gliomas: The <i>IDASPE</i> Prospective Study. | Neurology | 2023 |
| 36302709 | Human pegivirus identified in severe myelitis and optic neuritis in immunocompromised patients: A pathogenic role for a forgotten virus? | Revue Neurologique | 2023 |
| 36318828 | SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination era. | Leukemia and Lymphoma | 2023 |
| 37740653 | Hippocampal and neocortical BRAF mutant non-expansive lesions in focal epilepsies. | | 2023 |
| 37722087 | Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. | J Clin Oncol | 2023 |
| 38066305 | A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation. | Acta Neuropathol | 2023 |
| 37088804 | Lynch syndrome: influence of additional susceptibility variants on cancer risk. | | 2023 |
| 37272516 | Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma. | N Engl J Med | 2023 |
| 37269904 | Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability. | | 2023 |
| 37262394 | Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma. | | 2023 |
| 36632791 | EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. | Neuro Oncol | 2023 |
| 34995211 | Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield. | Critical Care Medicine | 2022 |
| 35973991 | Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. | Nat Commun | 2022 |
| 36367043 | Editorial: Advances in brain tumors management: new perspectives and challenges. | Current Opinion in Neurology | 2022 |
| 36083426 | Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion. | J Neurooncol | 2022 |
| 35601971 | Short-term outcomes associated with temozolomide or PCV chemotherapy for 1p/19q-codeleted WHO grade 3 oligodendrogliomas: A national evaluation. | Neurooncol Pract | 2022 |
| 36605194 | Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells. | | 2022 |
| 36456685 | Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response. | NPJ Precis Oncol | 2022 |
| 35063776 | Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials. | European Journal of Cancer | 2022 |
| 35038339 | Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma. | Neuro-Oncology | 2022 |
| 34507289 | Severity, timeline, and management of complications after stereotactic brain biopsy. | Journal of Neurosurgery | 2022 |
| 34878541 | Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making. | Neuro Oncol | 2022 |
| 34359346 | Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab. | Diagnostics | 2021 |
| 34126937 | Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS). | BMC Infectious Diseases | 2021 |
| 33478735 | BRAF mutation in overlapping form of Erdheim-Chester and Rosai Dorfman diseases: a unique case restricted to the central nervous system. | Revue Neurologique | 2021 |
| 33992635 | Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair. | Gastroenterology | 2021 |
| 34088874 | Sustained Tumor Control With MAPK Inhibition in <i>BRAF</i> V600-Mutant Adult Glial and Glioneuronal Tumors. | Neurology | 2021 |
| 33556428 | Costs and Outcomes of 1-year post-discharge care trajectories of patients admitted with infection due to antibiotic-resistant bacteria. | Journal of Infection | 2021 |
| 34187379 | Correction to: Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS). | BMC Infectious Diseases | 2021 |
| 33247715 | Quantification of aneuploidy in targeted sequencing data using ASCETS. | Bioinformatics | 2021 |
| 33387015 | SARS-CoV-2 infection in patients with primary central nervous system lymphoma. | Journal of Neurology | 2021 |
| 34396128 | Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic. | Neuro-Oncology Advances | 2021 |
| 34610309 | Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models. | Cell Reports | 2021 |
| 34829395 | A Predictive Clinical-Radiomics Nomogram for Survival Prediction of Glioblastoma Using MRI. | Diagnostics | 2021 |
| 34651608 | Mutational burden and immune recognition of gliomas. | Current Opinion in Oncology | 2021 |
| 34815016 | Liquid biopsy in neuro-oncology: are we finally there? | Annals of Oncology | 2021 |
| 33394574 | Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges. | Oncologist | 2020 |
| 32322066 | Mechanisms and therapeutic implications of hypermutation in gliomas. | Nature | 2020 |
| 32215616 | 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma. | Neuro-Oncology | 2020 |
| 32530764 | Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced Glioma. | J Clin Oncol | 2020 |
| 33029973 | Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity. | Journal of Clinical Neurology (Korea | 2020 |
| 33027142 | Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas? | Current Opinion in Neurology | 2020 |
| 31044146 | PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited. | Neurology: Neuroimmunology and NeuroInflammation | 2019 |
| 35100676 | Successful Targeting of an ATG7-RAF1 Gene Fusion in Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination. | JCO Precis Oncol | 2019 |
| 30506456 | A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study. | Applied Health Economics and Health Policy | 2019 |
| 30869047 | Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016. | Epidemiology and Infection | 2019 |
| 31346129 | Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations. | Oncologist | 2019 |
| 30801050 | Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade. | JCO Precis Oncol | 2018 |